Geode Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-27,321
| Closed | -$8K | – | 4131 |
|
|
2018
Q1 | $8K | Hold |
27,321
| – | – | ﹤0.01% | 4038 |
|
|
2017
Q4 | $45K | Sell |
27,321
-2,014
| -7% | -$3.47K | ﹤0.01% | 3938 |
|
|
2017
Q3 | $42K | Hold |
29,335
| – | – | ﹤0.01% | 3959 |
|
|
2017
Q2 | $47K | Sell |
29,335
-15,062
| -34% | -$33.8K | ﹤0.01% | 3969 |
|
|
2017
Q1 | $151K | Buy |
44,397
+6,174
| +16% | +$29.2K | ﹤0.01% | 3734 |
|
|
2016
Q4 | $197K | Buy |
38,223
+3,315
| +9% | +$57.4K | ﹤0.01% | 3628 |
|
|
2016
Q3 | $879K | Buy |
34,908
+4,251
| +14% | +$107K | ﹤0.01% | 3005 |
|
|
2016
Q2 | $757K | Buy |
30,657
+406
| +1% | +$11.5K | ﹤0.01% | 3030 |
|
|
2016
Q1 | $876 | Buy |
30,251
+287
| +1% | +$7.79K | ﹤0.01% | 2952 |
|
|
2015
Q4 | $1.11M | Sell |
29,964
-2,086
| -7% | -$92.1K | ﹤0.01% | 2855 |
|
|
2015
Q3 | $1.56M | Buy |
32,050
+3,627
| +13% | +$253K | ﹤0.01% | 2601 |
|
|
2015
Q2 | $1.96M | Buy |
28,423
+9,664
| +52% | +$447K | ﹤0.01% | 2515 |
|
|
2015
Q1 | $670K | Buy |
18,759
+7,112
| +61% | +$210K | ﹤0.01% | 3062 |
|
|
2014
Q4 | $147K | Hold |
11,647
| – | – | ﹤0.01% | 3696 |
|
|
2014
Q3 | $178K | Hold |
11,647
| – | – | ﹤0.01% | 3607 |
|
|
2014
Q2 | $315K | Hold |
11,647
| – | – | ﹤0.01% | 3361 |
|
|
2014
Q1 | $312K | Hold |
11,647
| – | – | ﹤0.01% | 3343 |
|
|
2013
Q4 | $286K | Sell |
11,647
-26
| -0.2% | -$670 | ﹤0.01% | 3308 |
|
|
2013
Q3 | $375K | Buy |
11,673
+4,668
| +67% | +$145K | ﹤0.01% | 3075 |
|
|
2013
Q2 | $208K | Buy |
+7,005
| New | +$261K | ﹤0.01% | 3221 |
|
Other funds holding ANTH
Geode Capital Management's ANTH Position: Q2 2018 in Review
Geode Capital Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 27,321 shares — an estimated $8K sold.
Geode Capital Management first reported a position in ANTH in Q2 2013 and held it in 20 quarters. The position peaked at $1.96M in Q2 2015. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.
- Geode Capital Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
- Geode Capital Management sold 27,321 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $8K.
- Geode Capital Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
- Geode Capital Management's Anthera Pharmaceuticals, Inc. position peaked at $1.96M in Q2 2015.
- 5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.
Based on Geode Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.